期刊文献+

前列腺癌放疗方法的剂量学研究 被引量:4

Dosimetry study of radiotherapy for prostate cancer
原文传递
导出
摘要 目的分析比较常规、三维适形和调强放疗局限期前列腺癌的最佳处方剂量。方法选取10例C期前列腺癌患者,采用CT定位和瓦里安Eclipse治疗计划系统对其进行3种治疗计划设计和计算,且均分为LFI组和EFI46 Gy+LFI组(即不需要和需要盆腔预防照射两种情况)。分析DVH曲线研究下列问题:(1)处方剂量80 Gy时,3种技术25%体积直肠的剂量(D25)、30%体积膀胱剂量(D30)。(2)同时满足直肠和膀胱最大耐受量时的靶区最大处方剂量。结果(1)处方剂量80 Gy时,LFI组直肠D25分别为77.22、69.18、57.85 Gy,膀胱D30为71.04、60.87、53.02 Gy;EFI46 Gy+ LFI组直肠D25分别为78.73、75.39、66.80 Gy,膀胱D30为71.05、59.96、52.20 Gy。(2)同时满足直肠D25为70 Gy和膀胱D30为65 Gy耐受剂量时,靶区最大处方剂量LFI组分别为68.26、77.47、90、52 Gy,各组差别均有统计学意义(P<0.05),EFI46 Gy+LFI组分别为66.27、69.29、77.39Gy,调强放疗与另外两组之间差异也有统计学意义(P〈0.01)。结论局限期前列腺癌同时满足直肠和膀胱最大耐受量时,LFI组中三维适形和调强放疗可达到根治剂量(77.47Gy和90.52Gy).EFI46Gy+LFI组中只有调强放疗可以达到根治剂量(77.39Gy)。 Objective To assess the optimum treatment dose of local field irradiation(LFI) or extended field irradiation(EFI) by common radiation therapy( Con-RT), three dimension conformal radiation therapy(3DCRT) and intensity modulated radiation therapy(IMRT) for prostate cancer. Methods A dosimetry study was carried out on 10 pathologically proven stage C prostate cancer patients. Dose volume histogram(DVH) of the above three techniques in LFI and EFI46 Gy + LFI group were carried out on every one of these 10 patients. The three techniques using rectum D25 ( absolute dose received by 25% volume ) and bladder D30 at the prescription dose level of 80 Gy for LFI and EFI46 Gy + LFI group were compared;the highest safe prescription dose of the three techniques in LFI and EFI46 Gy + LFI group were calculated. Retraits In LFI group, at the dose level of 80 Gy, the mean dose of the three techniques to the rectum D25 was 77.22,69.18,57.85 Gy, the bladder D30 with 71.04,60.87,53.02 Gy;in EFI46 Gy + LFI group, rectum D25 with 78.73,75.39,66.80 Gy, and bladder D30 with 71.05,59.96,52. 20 Gy. It should be emphasized that be sure the rectum D25 receives no more than 70 Gy and bladder D30 no more than 65 Gy(in LFI group: 68.2,77.47,90.52 Gy;in EFI46 Gy+LFI group:66.27,69.29,77.39 Gy). Conclusions Tryingto obtain the highest safe prescription dose which can satisfy the restriction of rectum D25 and bladder D30 using the three techniques in LFI and EFI46 Gy + LFI group. To find tenaciously 3DCRT (77.47 Gy) and IMRT (90.52 Gy) in LFI group and IMRT (77.39 Gy) in EFI46 Gy + LFI group is enables us to apply a radical treatment dose.
出处 《中华放射肿瘤学杂志》 CSCD 北大核心 2007年第2期125-128,共4页 Chinese Journal of Radiation Oncology
关键词 前列腺肿瘤 放射疗法 放疗技术 剂量学 Prostate neoplasms/radiotherapy Radiotherapy technology Dosimetry
  • 相关文献

参考文献23

  • 1Pollack A, Smith LG, von Eschenbach AC. External beam radiotherapy dose response characteristics of 1127 men with prostate cancer treated in the PSA era. Int J Radiat Oncol Biol Phys,2000,48:507-512.
  • 2Pollack A, Hanlon AL, Horwitz EM, et al. Prostate cancer radiotherapy dose response: an update of the fox chase experience. J Urol,2004,171:1132-1136.
  • 3Hanks GE, Leibel SA, Krall JM, et al. Patterns of care studies:dose-response observations for ocal control of adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys, 1984,10:401-409.
  • 4Smit WG, Helle PA, van Putten WL, et al. Late radiation damage in prostate cancer patients treated by high dose external radiotherapy in relation to rectal dose. Int J Radiat Oncol Biol Phys,1990,8 :23-29.
  • 5Pistenma DA, Bagshaw MA, Freiha FS. Extended-field radiation therapy for prostateadenocarcinoma: status report of a limited prospective trial. In: Johnson DE, Samuels ML, eds. Cancer of the genitourinary tract. New York: Raven Press, 1979. 229-247
  • 6Zelefsky MJ, Leibel SA, Kutcher GJ, et al. Three-dimensional conformal radiotherapy and dose escalation: where do we stand? Semin Radiat Oncol, 1998,8 : 107-114.
  • 7Zelefsky M J, Leibel SA, Gaudin PB, et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys, 1998,41:491-500.
  • 8Boersma LJ, van den Brink M, Bruce AM, et al. Estimation of the incidence of late bladder and rectum complications after high-dose(70-78 Gy) conformal radiotherapy for prostate cancer, using dose-volume histograms. Int J Radiat Oncol Biol Phys,1998,41:83-92.
  • 9Zelefsky MJ. Fuks Z, Hunt M ,et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome localized prostate cancer. J Urol ,2001,166 :2321-2322
  • 10Benk VA, Adams JA, Shipley WU, et al. Late rectal bleeding following combined X-ray and proton high dose irradiation for patients with stages T3-T4 prostate carcinoma. Int J Radiat Oncol Biol Phys,1993,26:551-557.

同被引文献46

  • 1房辉,李晔雄,余子豪,刘新帆,金晶,韩嘉珠,钱图南.前列腺癌三维适形和调强放疗的初步结果[J].中华放射肿瘤学杂志,2006,15(3):197-200. 被引量:16
  • 2华立新,眭元庚.对前列腺癌根治性治疗后生化复发的认识及对策[J].中华泌尿外科杂志,2006,27(11):790-791. 被引量:2
  • 3叶定伟,周芳坚.前列腺癌根治术后复发的诊断和治疗[J].中国癌症杂志,2007,17(3):193-198. 被引量:4
  • 4叶定伟 朱耀.中国前列腺癌的发病趋势[J].中国临床肿瘤学教育专辑,2007,:616-620.
  • 5[2]Pound CR,Partin AW,Eisenberger MA,et al.Natural history of progression after PSA elevation following radical prostatectomy[J].JAMA,1999,281:1591-1597.
  • 6[3]Babaian PJ,Troncoso P,Bhadkamkar VA,et al.Analysis of clinic pathologic factors Predicting outcome after radical prostatectomy[J].Cancer,2001,91:1414-1422.
  • 7[4]Peschel RE,Robnett TJ,Hesse D,et al.PSA based review of adjuvant and salvage radiation therapy vs.observation in postoperative prostate cancer patients[J].Int J Cancer,2000,90(1):29-32.
  • 8[5]Ahxandre A Jacinto,Angelo BS Fede,Livia A Fagundes,et al.Salvase radiotherapy for biochemical relapse after complete PSA response following radical prostateetomy:outcome and prognostic factors for patients who have rlever received hormonal therapy[J].Badiation Oncology,2007,2:8-14.
  • 9[6]Michel Bolla,Hein van Poppel,Laurence Collette,et al.Postoperative radiotherapy after radical prostatectomy:a randomised controlled trial(EORTC trial 22911)[J].Lancet,2005,366:572-578.
  • 10[7]Moul JW.Prostate specific antigen only prognnssion of prostate cancer[J].J Urol,2000,163:1632-1642.

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部